183 related articles for article (PubMed ID: 3362748)
1. Electron microscopical morphometry of pituitary adenomas. Comparison of tumours in acromegaly and hyperprolactinemia.
Saeger W; Kant P; Caselitz J; Lüdecke DK
Pathol Res Pract; 1988 Feb; 183(1):17-24. PubMed ID: 3362748
[TBL] [Abstract][Full Text] [Related]
2. Light and electron microscopical morphometry of pituitary adenomas in hyperprolactinemia.
Saeger W; Mohr K; Caselitz J; Lüdecke DK
Pathol Res Pract; 1986 Oct; 181(5):544-50. PubMed ID: 3024139
[TBL] [Abstract][Full Text] [Related]
3. Ultrastructural study of mixed growth hormone & prolactin secreting pituitary adenomas.
Sarkar C; Dinda AK; Roy S; Kochupillai N; Kharbanda K; Tandon PN
Indian J Med Res; 1992 Aug; 96():209-14. PubMed ID: 1428057
[TBL] [Abstract][Full Text] [Related]
4. Ultrastructural-morphometric effects of radiotherapy on pituitary adenomas in acromegaly.
Betzold JM; Saeger W; Lüdecke DK
Exp Clin Endocrinol; 1992; 100(3):106-11. PubMed ID: 1305059
[TBL] [Abstract][Full Text] [Related]
5. Electron microscopical morphometry of GH producing pituitary adenomas in comparison with normal GH cells.
Saeger W; Rübenach-Gerz K; Caselitz J; Lüdecke DK
Virchows Arch A Pathol Anat Histopathol; 1987; 411(5):467-72. PubMed ID: 3116761
[TBL] [Abstract][Full Text] [Related]
6. In-vitro effects of bromocriptine on isolated pituitary adenoma cells. Ultrastructural and morphometrical studies.
Saeger W; Thiel M; Caselitz J; Lüdecke DK
Pathol Res Pract; 1985 Dec; 180(6):697-704. PubMed ID: 3832005
[TBL] [Abstract][Full Text] [Related]
7. Somatomammotrophic cells in GH-secreting and PRL-secreting human pituitary adenomas.
Bassetti M; Brina M; Spada A; Giannattasio G
J Endocrinol Invest; 1989 Nov; 12(10):705-12. PubMed ID: 2614009
[TBL] [Abstract][Full Text] [Related]
8. Pituitary adenoma in Carney complex: an immunohistochemical, ultrastructural, and immunoelectron microscopic study.
Kurtkaya-Yapicier O; Scheithauer BW; Carney JA; Kovacs K; Horvath E; Stratakis CA; Vidal S; Vella A; Young WF; Atkinson JL; Lloyd RV; Kontogeorgos G
Ultrastruct Pathol; 2002; 26(6):345-53. PubMed ID: 12537759
[TBL] [Abstract][Full Text] [Related]
9. Effect of vasoactive intestinal polypeptide (VIP) on growth hormone (GH) and prolactin (PRL) release and cell morphology in human pituitary adenoma cell cultures.
Fazekas I; Bácsy E; Varga I; Slowik F; Bálint K; Pásztor E; Czirják S; Gláz E
Folia Histochem Cytobiol; 2000; 38(3):119-27. PubMed ID: 10970071
[TBL] [Abstract][Full Text] [Related]
10. Mixed growth hormone- and prolactin cell adenomas of the pituitary gland. An immunoelectron microscopic study.
Holm R; Nesland JM; Attramadal A; Reinli S; Johannessen JV
J Submicrosc Cytol Pathol; 1989 Apr; 21(2):339-50. PubMed ID: 2752363
[TBL] [Abstract][Full Text] [Related]
11. Morphometric study of normal and adenomatous pituitary somatotrophs in humans.
Tsanaclis AM; Sesso A
Pathol Res Pract; 1988 Sep; 183(5):572-6. PubMed ID: 3237546
[TBL] [Abstract][Full Text] [Related]
12. Distribution of growth hormone and prolactin in secretory granules of the normal and neoplastic human adenohypophysis.
Zurschmiede C; Landolt AM
Virchows Arch B Cell Pathol Incl Mol Pathol; 1987; 53(5):308-15. PubMed ID: 2889294
[TBL] [Abstract][Full Text] [Related]
13. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment.
Teramoto A; Sanno N; Tahara S; Osamura YR
Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102
[TBL] [Abstract][Full Text] [Related]
14. Prolactin-secreting adenomas. A light and electron microscopical study.
Robert F; Hardy J
Arch Pathol; 1975 Dec; 99(12):625-33. PubMed ID: 1239266
[TBL] [Abstract][Full Text] [Related]
15. Acromegaly with hyperprolactinemia developed after bilateral adrenalectomy in a patient with Cushing's syndrome due to adrenocortical nodular hyperplasia.
Ogo A; Haji M; Natori S; Kanzaki T; Kabayama Y; Osamura RY; Nawata H; Ibayashi H
Endocr J; 1993 Feb; 40(1):17-25. PubMed ID: 7951491
[TBL] [Abstract][Full Text] [Related]
16. Morphological studies on mixed growth hormone (GH)- and prolactin (PRL)-secreting human pituitary adenomas. Coexistence of GH and PRL in the same secretory granule.
Bassetti M; Spada A; Arosio M; Vallar L; Brina M; Giannattasio G
J Clin Endocrinol Metab; 1986 Jun; 62(6):1093-100. PubMed ID: 3084531
[TBL] [Abstract][Full Text] [Related]
17. Effects of octreotide on morphology of pituitary adenomas in acromegaly.
Sautner D; Saeger W; Tallen G; Lüdecke DK; Rehpenning W
Pathol Res Pract; 1993 Nov; 189(9):1044-51. PubMed ID: 8302723
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical detection of glycoprotein hormone alpha subunit in somatoprolactinic and pure somatotroph adenomas.
Vantyghem MC; Cortet C; Bauters C; Gevaert MH; Dewailly D; Lefebvre J; Mazzucca M
J Endocrinol Invest; 1998; 21(7):434-40. PubMed ID: 9766257
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of secretory granules of silent pituitary adenomas.
Holck S; Wewer UM; Albrechtsen R
Mod Pathol; 1988 May; 1(3):212-5. PubMed ID: 3237702
[TBL] [Abstract][Full Text] [Related]
20. [Silent adenoma type 3: the importance of the ultrastructural study in the differential diagnosis of pituitary adenoma associated with hyperprolactinemia in a case].
Quevedo I; Rodríguez JA; Gejman R; Méndez J
Rev Med Chil; 2001 Mar; 129(3):295-8. PubMed ID: 11372297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
